LCI Stock Recent News Lannett Co Inc (LCI) 46.88 11/14/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Lannett Co Inc (LCI) 46.88 $LCI

Merck KGaA Q3 Earnings Rise Y/Y, 2014 View Upgraded - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 1:20PM CST
Merck KGaA (MKGAF) reported third-quarter 2014 earnings of $1.53 per American Depositary Receipt (ADR), up 0.2% from the year-ago quarter.
LCI: 46.88 (-1.40), VRX: 134.21 (+2.31), ADHD: 3.66 (+0.06)

Flamel Technologies (FLML) in Focus: Stock Rises 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 8:46AM CST
Flamel Technologies (FLML) was a big mover last session, with shares rising just over 11% on the day.
LCI: 46.88 (-1.40), FLML: 13.17 (-0.22), ADHD: 3.66 (+0.06), SCMP: 11.30 (+0.20)

Sucampo (SCMP) Worth Watching: Stock Moves 7.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 8:25AM CST
Sucampo Pharmaceuticals (SCMP) was a big mover last session, with shares rising over 7% on the day.
LCI: 46.88 (-1.40), SHPG: 202.62 (+0.20), SCMP: 11.30 (+0.20), CEMP: 13.60 (-0.56)

Avanir Faces Regulatory Setback, AVP-825 Could Be Delayed - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 4:40PM CST
Avanir Pharmaceuticals, Inc. (AVNR) received a disappointing preliminary feedback from the FDA regarding its new drug application for AVP-825.
LCI: 46.88 (-1.40), AVNR: 13.13 (-0.01), AUXL: 32.17 (-0.18), GSK: 45.74 (+0.08)

UCB to Sell Generics Business, Focus on Core Segments - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 4:30PM CST
UCB SA (UCBJF) entered into an agreement with Advent International and Avista Capital Partners for the sale of its specialty generics subsidiary for $1.525 billion.
LCI: 46.88 (-1.40), LLY: 67.33 (-0.35), GSK: 45.74 (+0.08), NVS: 93.95 (-0.43)

Stocks Rise; IBD 50 Stocks Lead The Way
at Investor's Business Daily - Mon Nov 10, 3:32PM CST
The stock market finished higher Monday, with no major news and a smattering of morning earnings reports. Volume ran lighter than Friday, according to preliminary data. The Nasdaq rose 0.4%; the S&P 500 gained 0.3% and the Dow Jones industrial...
AMBA: 47.84 (+0.10), WWAV: 36.56 (+0.42), BCC: 37.03 (-0.16), LCI: 46.88 (-1.40), BIDU: 249.70 (+5.61), DF: 16.61 (-0.06)

La Jolla Pharmaceutical (LJPC) in Focus: Stock Surges 10.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:44AM CST
La Jolla Pharmaceutical Co. (LJPC) was a big mover last session, as the company saw its shares surge over 10% on the day
ENDP: 66.26 (-0.84), LCI: 46.88 (-1.40), BCRX: 10.07 (-0.32), LJPC: 11.06 (unch)

Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 37.03 (-0.16), LCI: 46.88 (-1.40), AKRX: 38.21 (+0.53), AFSI: 52.48 (+0.32), EXPE: 87.93 (+1.44), FFIV: 128.88 (+2.73), SLXP: 102.32 (+5.33), MPWR: 45.46 (+0.59), TMH: 54.48 (+0.57), ATHM: 44.58 (+1.59)

Update: Lannett Fiscal Q1 2015 Earnings
ONeil Trader - at Seeking Alpha - Thu Nov 06, 1:13AM CST

LCI: 46.88 (-1.40)

Let Major Indexes Dictate Buy, Sell Decisions
at Investor's Business Daily - Wed Nov 05, 5:01PM CST
The S&P 500 and Nasdaq composite serve as guideposts to the market's health. Ignore them at your own peril. Every day, IBD analyzes the action of these major stock averages to determine whether the market is in an uptrend (healthy) or a correction...
LCI: 46.88 (-1.40), AKRX: 38.21 (+0.53), ORLY: 179.88 (-1.75), AFSI: 52.48 (+0.32), CELG: 104.05 (-3.38)

Stocks Narrow Losses; Airlines Lead
at Investor's Business Daily - Tue Nov 04, 12:29PM CST
Stocks narrowed losses near midday Tuesday, but some leaders remained under pressure. The Nasdaq fell 0.6%, the S&P 500 dropped 0.4%, and the Dow Jones industrial average was down a fraction. Wal-Mart Stores (WMT), Travelers (TRV) and Procter &...
LCI: 46.88 (-1.40), SAVE: 76.15 (-1.95), WMT: 82.96 (+0.02), PG: 88.11 (-0.49), ATHM: 44.58 (+1.59), TXRH: 31.86 (-0.57), LUV: 38.95 (-0.51), TRV: 102.43 (-0.80)

Insider Trading Alert - LGF, OMI And LCI Traded By Insiders
at The Street - Tue Nov 04, 10:35AM CST
Stocks with insider trader activity include LGF, OMI and LCI
LCI: 46.88 (-1.40), LGF: 35.11 (-0.11), OMI: 33.74 (-0.27)

Lannett's (LCI) CEO Arthur Bedrosian on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 03, 10:22PM CST

LCI: 46.88 (-1.40)

Lannett ups revenue outlook
at Investor's Business Daily - Mon Nov 03, 5:26PM CST
The generic-drug maker's adjusted EPS skyrocketed 327% to 94 cents in Q1 '15, passing views by 10 cents. Revenue soared 104% to $93.4 mil, topping expectations for $91.9 mil. Lannett (LCI) raised its full-year '15 revenue range by $20 mil, to $370...
LCI: 46.88 (-1.40)

Sprint, RetailMeNot Disappoint The Street After Hours
at Investor's Business Daily - Mon Nov 03, 3:57PM CST
Stocks finished mixed Monday, with volume lower across the board. Oil dropped more than $2 a barrel and was trading near $78. After the close, wireless carrier Sprint (S) dropped sharply after announcing disappointing Q4 results. It reported a loss...
LCI: 46.88 (-1.40), S: 5.05 (+0.05), JAZZ: 174.57 (+1.59), SALE: 15.03 (+0.34), KORS: 72.06 (+1.32), PCLN: 1,172.96 (+4.95), BABA: 115.10 (+0.26)

Lannett beats by $0.10, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 3:09PM CST

LCI: 46.88 (-1.40)

Lannett Reports Net Sales of $93 Million, EPS of $0.94 for Fiscal 2015 First Quarter
Business Wire - Mon Nov 03, 3:05PM CST
Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2015 first quarter ended September 30, 2014.
LCI: 46.88 (-1.40)

Stocks Open Mixed And Quiet; Chipmakers In Motion
at Investor's Business Daily - Mon Nov 03, 9:35AM CST
Stocks wobbled in a mixed start Monday on a cross-current of company news and economic reports. The Nasdaq climbed 0.3% and the Dow Jones industrial average dipped 0.1%, but both moved in soft trade. The S&P 500 added a fraction. Volume was weak on...
AMBA: 47.84 (+0.10), LCI: 46.88 (-1.40), MU: 32.62 (-0.32), SWKS: 62.80 (+2.09), SAPE: 24.68 (unch), AFSI: 52.48 (+0.32), CRUS: 19.15 (+0.13), LH: 98.84 (-0.72), CVD: 100.30 (-0.23)

Lannett Announces Positive FDA Inspection Results
Business Wire - Mon Nov 03, 6:54AM CST
Lannett Company, Inc. (NYSE: LCI) today announced that the U.S. Food and Drug Administration (FDA) has completed its cGMP compliance inspection of Lannett's wholly owned subsidiary Cody Laboratories, Inc. (Cody), a manufacturer of active pharmaceutical ingredients (APIs) and finished dosage form products. The inspection commenced on Monday, October 27, 2014, and was completed on Thursday, October 30, 2014.
LCI: 46.88 (-1.40)

Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:35PM CST

RKT: 55.60 (-0.27), HLF: 38.50 (+0.65), EGAN: 5.19 (-0.19), CUTR: 10.53 (+0.19), DXPE: 65.54 (-1.19), AEIS: 20.64 (+0.11), NOR: 3.90 (-0.06), KBR: 18.85 (+0.12), SGY: 22.90 (+1.04), RTEC: 9.16 (+0.07), PKT: 7.10 (+0.05), OGS: 38.13 (+0.15), BKH: 53.89 (-0.53), KAMN: 40.86 (-0.27), EOX: 2.76 (+0.06), MR: 31.06 (-0.16), RKUS: 12.32 (+0.23), LCI: 46.88 (-1.40), NBIX: 18.92 (-0.22), PQ: 4.12 (+0.17), RBC: 71.12 (-0.03), CHGG: 6.90 (+0.04), AIG: 53.90 (-0.60), MRO: 32.36 (+0.41), GRT: 13.84 (-0.02), EPAM: 49.64 (+0.47), CKP: 12.70 (-0.14), SBRA: 27.12 (-0.53), MDU: 25.09 (+0.09), NTRI: 18.36 (-0.14), ELNK: 4.22 (+0.04), EQC: 25.60 (-0.33), CVD: 100.30 (-0.23), IART: 47.64 (-0.47), FN: 17.81 (+0.31), APL: 33.13 (+0.13), BDE: 8.81 (-0.09), AGU: 100.28 (+0.52), PLOW: 23.18 (+0.22), REG: 60.74 (-0.70), QLYS: 36.63 (+0.96), GALE: 1.87 (-0.01), ANV: 1.37 (+0.17), ININ: 47.97 (+1.02), FTR: 6.81 (+0.08), GTY: 18.25 (-0.17), MCEP: 16.17 (-0.64), CYH: 45.11 (-1.09), SKH: 7.10 (+0.05), ACXM: 18.56 (+0.03), PL: 69.70 (-0.18), RLD: 11.52 (-0.03), CXW: 36.00 (-0.15), SALE: 15.03 (+0.34), ENH: 57.67 (-0.10), CRK: 11.81 (+0.44), AMTG: 16.26 (+0.05), OTTR: 29.17 (-0.22), NLS: 14.53 (+0.25)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 110

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 394

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 570

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Anthropic Bears Get New Tools, But Daily Risk Bites

Updated Category News Views 64

A $81.3 Billion Offering Invites Fast Money Anthropic arrived in public markets with the sort of numbers that make traders reach for both a calculator and a helmet. The company priced 980 million Class A shares at $83 on November 18, 2026, raising roughly $81.3 billion, then opened at $111.50 when it began Nasdaq trading on November 19. That is a monster debut by any...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 140

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Australia Leads TTW's 2027 Global Travel Country List

Updated Category News Views 43

A travel ranking is a map, not a balance sheet, and that distinction matters more than the glossy numbering. TTW has put Australia at the head of its editorial list of the 50 best countries to visit in 2027, followed by Switzerland, Japan, Canada and Thailand. Fair enough. Those are formidable tourism brands with the scenery, infrastructure and cultural pull to back up...

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 69

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 459

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading

Top 5 Most Recently Viewed Articles

3Srobotics Breaks Ground with North American Debut

Updated Category News Views 204

3Srobotics Steps Into the Big League The sweltering buzz of FABTECH 2026 in Las Vegas signals more than just another industry tradeshow; it's the stage upon which 3Srobotics made its North American debut. In a span shorter than it takes most companies to get serious about their business cards, 3Srobotics has already nailed three funding rounds, snagging tens of millions...

Continue Reading
Uganda Plans Major Spending Cuts and Reduced Borrowing for 2025

Updated Category News Views 912

Uganda's government announced a hefty shift in its fiscal playbook back in 2024, aiming to cut spending by over 20% and slash domestic borrowing by more than half for the upcoming 2025/26 fiscal year. This wasn’t just some routine budgetary tweak; it was a necessary maneuver amidst growing alarm about the nation's spiraling public debt. You know these moves grab...

Continue Reading
Vivos Therapeutics to Share Q1 2025 Results and Updates Soon

Updated Category News Views 257

Vivos Therapeutics Prepares for Q1 2025 Financial Disclosure Vivos Therapeutics, Inc. (NASDAQ: VVOS), a pioneering company in the medical devices sector, is gearing up to release its financial results for the first quarter of 2025. This announcement is anticipated to take place following the market's closure on a Thursday in May 2025. The management team is set to hold a...

Continue Reading
Join XBP Global for the Annual Turkey Trot This Thanksgiving

Updated Category News Views 217

XBP Global Welcomes You to the 11th Annual Turkey Trot XBP Global Holdings, Inc. (NASDAQ: XBP) is thrilled to invite the community to the 11th Annual Palisades Turkey Trot, a cherished tradition returning this Thanksgiving morning. Held at Palisades Green, this year's event promises excitement with new 5K and 10K courses that enhance the festive atmosphere of the...

Continue Reading
Market Reaction to CEO Departure and Boot Barn's Strong Quarter

Updated Category News Views 317

Boot Barn Stock Forecast Amid CEO Transition and Solid Performance In the latest developments regarding Boot Barn (NYSE: BOOT), analysts at Craig-Hallum have made notable adjustments to their stock price outlook. The price target has been revised to $160 from a previous $162, maintaining a Hold rating. The adjustments come in light of the company's impressive performance...

Continue Reading